Vall d’Hebron is looking for volunteers to participate in the Phase IIb study of the HIPRA vaccine against COVID-19

Vall d’Hebron is looking for volunteers over the age of 18 who have received the Pfizer-BioNTech Comirnaty vaccine against COVID-19 at least 6 months ago, to study a new vaccine under research that it is developing against COVID-19.

Volunteers will receive a booster dose of the new vaccine under investigation or a vaccine already on the market and will be monitored for up to a year to find out their safety and response (immunity).

The study has bee evaluated by the Ethics Committee of the Hospital Clínic de Barcelona and the Spanish Agency for Medicines and Health Products (AEMPS) with the participation of several Spanish hospitals.

Interested people can contact Vall d’Hebron via this form, via email at vacunacovid@vhebron.net or via phone at 692 08 37 39 or 93 489 42 37 (8AM-5PM).